Cargando…
New Charge Transfer Complexes of K(+)-Channel-Blocker Drug (Amifampridine; AMFP) for Sensitive Detection; Solution Investigations and DFT Studies
UV–Vis spectroscopy was used to investigate two new charge transfer (CT) complexes formed between the K(+)-channel-blocker amifampridine (AMFP) drug and the two π-acceptors 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) and tetracyanoethylene (TCNE) in different solvents. The molecular composition of...
Autores principales: | Alghanmi, Reem M., Basha, Maram T., Soliman, Saied M., Alsaeedi, Razan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512129/ https://www.ncbi.nlm.nih.gov/pubmed/34641581 http://dx.doi.org/10.3390/molecules26196037 |
Ejemplares similares
-
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine
por: Lindquist, Sabine, et al.
Publicado: (2011) -
Amifampridine Phosphate (Firdapse) Is Effective in a Confirmatory Phase 3 Clinical Trial in LEMS
por: Shieh, Perry, et al.
Publicado: (2019) -
Investigation of N-Acetyltransferase 2-Mediated Drug Interactions of Amifampridine: In Vitro and In Vivo Evidence of Drug Interactions with Acetaminophen
por: Park, Yeo-Dim, et al.
Publicado: (2023) -
Conceptual DFT, QTAIM, and Molecular Docking Approaches to Characterize the T-Type Calcium Channel Blocker Anandamide
por: Rangel-Galván, Maricruz, et al.
Publicado: (2022)